08:00 , Jan 19, 2015 |  BC Week In Review  |  Company News

uniQure management update

uniQure N.V. (NASDAQ:QURE), Amsterdam, the Netherlands   Business: Hematology, Neurology, Endocrine/Metabolic   Hired: Matthew Kapusta as CFO, formerly SVP of corporate development, strategic planning and national accounts at AngioDynamics Inc.  ...
08:00 , Dec 16, 2013 |  BC Week In Review  |  Company News

AngioDynamics management update

AngioDynamics Inc. (NASDAQ:ANGO), Latham, N.Y.   Business: Cancer, Cardiovascular   Departing: Stephen McGill as SVP and general manager   Transitioned: John Soto to chief commercial officer, a newly created position, from SVP of AngioDynamics' global...
08:00 , Dec 3, 2012 |  BC Week In Review  |  Company News

AngioDynamics management update

AngioDynamics Inc. (NASDAQ:ANGO), Latham, N.Y.   Business: Cancer, Cardiovascular   Retiring: EVP and CFO Joseph Gersuk, effective Jan. 31, 2013; he will be succeeded by Mark Frost, SVP of administration and CFO of Albany Molecular...
07:00 , Oct 22, 2012 |  BC Week In Review  |  Company News

AngioDynamics, Vortex Medical Inc. deal

AngioDynamics completed its previously announced acquisition of medical device company Vortex Medical for $15 million in cash, plus cash payments based on net sales of the AngioVac system over 10 years. The system is comprised...
07:00 , Oct 15, 2012 |  BC Week In Review  |  Company News

AngioDynamics, biolitec Inc. cardiovascular, cancer news

A judge in the U.S. District Court for the Northern District of New York awarded AngioDynamics $23.2 million in damages in a suit against biolitec. AngioDynamics filed suit in 2008 alleging biolitec violated a 2002...
07:00 , Oct 15, 2012 |  BC Week In Review  |  Company News

AngioDynamics, Vortex Medical deal

AngioDynamics will acquire medical device company Vortex Medical for $15 million in cash, plus cash payments based on net sales of the AngioVac system over 10 years. AngioDynamics will make a minimum payment of about...
07:00 , Oct 8, 2012 |  BC Week In Review  |  Company News

AngioDynamics management update

AngioDynamics Inc. (NASDAQ:ANGO), Latham, N.Y.   Business: Cancer, Cardiovascular   Hired: Louis Mazzarese as SVP and chief regulatory officer; and John Soto as SVP of the peripheral vascular global franchise, formerly SVP of the global...
07:00 , May 30, 2011 |  BC Week In Review  |  Company News

AngioDynamics, BTG sales and marketing update

AngioDynamics announced that it will not extend its distribution deal with BTG for LC Bead in the U.S. beyond the deal's Dec. 31 expiration date. In April 2006, BTG granted AngioDynamics rights to distribute the...
07:00 , May 9, 2011 |  BC Week In Review  |  Company News

Delcath management update

Delcath Systems Inc. (NASDAQ:DCTH), New York, N.Y.   Business: Drug delivery, Cancer   Hired: Harold Mapes as EVP of global operations, a newly created position, formerly SVP of operations at AngioDynamics Inc.  ...
08:00 , Dec 6, 2010 |  BioCentury  |  Strategy

BTG's parallel worlds

Two years ago BTG plc took the first step toward becoming a specialty pharma by acquiring Protherics plc , an acute care company with two marketed products in the U.S. Now, BTG is adding a...